New Study Findings Favor Use Of New Generation Of Diabetes Treatment
A new study conducted by researchers from Brigham and Women’s Hospital might pave the way for new and more efficient treatments for diabetes patients. The study evaluated a drug called ertugliflozin, an SGLT2 inhibitor that is usually prescribed to patients who have type 2 diabetes to help keep their blood sugar in control. The study …
New Study Findings Favor Use Of New Generation Of Diabetes Treatment Read More »









